{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:17:31Z","timestamp":1788427051910,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.coi.2026.102818","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:42:13Z","timestamp":1784590933000},"page":"102818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The role of artificial intelligence in clinical trials in adult and pediatric rheumatology"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1244-0789","authenticated-orcid":false,"given":"Saverio","family":"La Bella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"Rebollo-Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Capitoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Breda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"La Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Venerito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102818_bib1","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1093\/rheumatology\/keaf455","article-title":"The evolving landscape of rheumatic drugs and their indications in paediatric and adolescent care","volume":"64","author":"Ciurtin","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2026.102818_bib2","article-title":"Juvenile idiopathic arthritis","volume":"8","author":"Martini","year":"2022","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.coi.2026.102818_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.14745","article-title":"Demographic characteristics of participants in rheumatoid arthritis randomized clinical trials: a systematic review","volume":"2","author":"Strait","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.coi.2026.102818_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.2024.4088","article-title":"The integration of clinical trials with the practice of medicine: repairing a house divided","volume":"332","author":"Angus","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.coi.2026.102818_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/BOR.0000000000001087","article-title":"AI am the future: artificial intelligence in pediatric rheumatology","volume":"37","author":"La Bella","year":"2025","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.coi.2026.102818_bib6","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s00296-024-05661-x","article-title":"The emerging paradigm in pediatric rheumatology: harnessing the power of artificial intelligence","volume":"44","author":"Koker","year":"2024","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.coi.2026.102818_sbref7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ero.2026.03.001","article-title":"Artificial intelligence in rheumatology and paediatric rheumatology: insights from an international survey by EMEUNET","volume":"2","author":"La Bella","year":"2026","journal-title":"EULAR Rheumatol Open"},{"key":"10.1016\/j.coi.2026.102818_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41584-025-01337-3","article-title":"Advances in AI-based patient stratification for rheumatic diseases","volume":"22","author":"Knevel","year":"2026","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102818_bib9","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102818_bib10","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","article-title":"A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis","volume":"56","author":"Ruperto","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102818_bib11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102818_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2026.102818_bib13","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102818_bib14","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102818_bib15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/annrheumdis-2014-205351","article-title":"Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial","volume":"74","author":"Brunner","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102818_bib16","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2020-217101","article-title":"Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial","volume":"79","author":"Brunner","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102818_bib17","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(21)01255-1","article-title":"Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial","volume":"398","author":"Ruperto","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2026.102818_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/ard-2022-222849","article-title":"Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial","volume":"82","author":"Brunner","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102818_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(23)00921-2","article-title":"Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial","volume":"402","author":"Ramanan","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2026.102818_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102818_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102818_bib22","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/ard-2024-225882","article-title":"Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS-SPARTAN collaboration","volume":"83","author":"Lambert","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102818_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41584-025-01329-3","article-title":"Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiative","volume":"22","author":"Proft","year":"2026","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102818_bib24","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.2026-0377","article-title":"GRAPPA Research Projects: development of criteria for axial psoriatic arthritis and definitions of complex-to-manage and treatment-refractory psoriatic arthritis","author":"Letarouilly","year":"2026","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2026.102818_bib25","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/jamia\/ocae243","article-title":"Artificial intelligence for optimizing recruitment and retention in clinical trials: a scoping review","volume":"31","author":"Lu","year":"2024","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.coi.2026.102818_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JOP.2012.000646","article-title":"Effort required in eligibility screening for clinical trials","volume":"8","author":"Penberthy","year":"2012","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.coi.2026.102818_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12911-015-0149-3","article-title":"Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients","volume":"15","author":"Ni","year":"2015","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.coi.2026.102818_bib28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/acr2.11289","article-title":"Improving the efficiency of clinical trial recruitment using an ensemble machine learning to assist with eligibility screening","volume":"3","author":"Cai","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.coi.2026.102818_bib29","article-title":"Utilizing large language models for enhanced clinical trial matching: a study on automation in patient screening","volume":"16","author":"Beattie","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.coi.2026.102818_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-025-01256-0","article-title":"Real-world validation of a multimodal LLM-powered pipeline for high-accuracy clinical trial patient matching","volume":"5","author":"Callies","year":"2025","journal-title":"Commun Med"},{"key":"10.1016\/j.coi.2026.102818_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244877","article-title":"Towards remote monitoring in pediatric care and clinical trials-tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity, heart rate and sleep in healthy children","volume":"16","author":"Kruizinga","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2026.102818_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ero.2025.05.003","article-title":"Five years of the digital rheumatology network: insights and future directions","volume":"1","author":"Chan","year":"2025","journal-title":"EULAR Rheumatol Open"},{"key":"10.1016\/j.coi.2026.102818_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-026-01450-8","article-title":"Challenges and potential of using digital biomarkers in healthcare and clinical trials","volume":"6","author":"Lieberwirth","year":"2026","journal-title":"Commun Med"},{"key":"10.1016\/j.coi.2026.102818_sbref34","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-024-01013-y","article-title":"Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis","volume":"7","author":"Creagh","year":"2024","journal-title":"npj Digit Med"},{"key":"10.1016\/j.coi.2026.102818_bib35","doi-asserted-by":"crossref","DOI":"10.2196\/56816","article-title":"Development and delivery of an integrated digital health care approach for children with juvenile idiopathic arthritis: usability study","volume":"7","author":"Butler","year":"2024","journal-title":"JMIR Pediatr Parent"},{"key":"10.1016\/j.coi.2026.102818_sbref36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000525061","article-title":"Dorsal finger fold recognition by convolutional neural networks for the detection and monitoring of joint swelling in patients with rheumatoid arthritis","volume":"6","author":"H\u00fcgle","year":"2022","journal-title":"Digit Biomark"},{"key":"10.1016\/j.coi.2026.102818_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-026-00639-7","article-title":"A deep learning system for diagnosis of rheumatoid arthritis on digital hand photographs","volume":"10","author":"Hanaoka","year":"2026","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.coi.2026.102818_bib38","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2024.08.069","article-title":"Artificial intelligence in cardiovascular clinical trials","volume":"84","author":"Cunningham","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.coi.2026.102818_bib39","doi-asserted-by":"crossref","DOI":"10.2196\/78417","article-title":"New doc on the block: scoping review of AI systems delivering motivational interviewing for health behavior change","volume":"27","author":"Karve","year":"2025","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.coi.2026.102818_bib40","doi-asserted-by":"crossref","DOI":"10.2196\/79677","article-title":"The development and use of AI chatbots for health behavior change: scoping review","volume":"28","author":"Fu","year":"2026","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.coi.2026.102818_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-097528","article-title":"Evaluating the performance of large language models in health education for patients with ankylosing spondylitis\/spondyloarthritis: a cross-sectional, single-blind study in China","volume":"15","author":"Ren","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.coi.2026.102818_bib42","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2665-9913(25)00370-4","article-title":"LupusGPT: an AI-driven information model for patients with systemic lupus erythematosus","volume":"8","author":"Karakikla-Mitsakou","year":"2026","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2026.102818_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-025-06023-x","article-title":"Patient experiences, attitudes, and profiles regarding artificial intelligence in rheumatology: a German National Cross-sectional Survey study","volume":"45","author":"Labinsky","year":"2025","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.coi.2026.102818_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-024-01011-0","article-title":"Reliability of a generative artificial intelligence tool for pediatric familial Mediterranean fever: insights from a multicentre expert survey","volume":"22","author":"La Bella","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.coi.2026.102818_bib45","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1093\/rheumatology\/keaf329","article-title":"Global variations in artificial intelligence-generated information on juvenile idiopathic arthritis","volume":"64","author":"La Bella","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2026.102818_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/ETLS20243003","article-title":"The impact of artificial intelligence on biomarker discovery","volume":"8","author":"Javaid","year":"2025","journal-title":"Emerg Top Life Sci"},{"key":"10.1016\/j.coi.2026.102818_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-60987-9","article-title":"Deep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis","volume":"16","author":"Lewis","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102818_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-025-01997-1","article-title":"Location and amount of joint involvement differentiates rheumatoid arthritis into different clinical subsets","volume":"8","author":"Maarseveen","year":"2025","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.coi.2026.102818_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104946","article-title":"Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts","volume":"100","author":"Shoop-Worrall","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coi.2026.102818_bib50","article-title":"Advancing artificial intelligence in rheumatology from evidence to practice","volume":"17","author":"Benavent","year":"2025","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.coi.2026.102818_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2026.102818_bib52","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1038\/s41591-025-03953-8","article-title":"The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence","volume":"31","author":"Sounderajah","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102818_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2026.102818_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111507","article-title":"The crucial role of explainability in healthcare AI","volume":"176","author":"Beger","year":"2024","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.coi.2026.102818_sbref55","doi-asserted-by":"crossref","DOI":"10.1016\/j.compeleceng.2024.109370","article-title":"A review of explainable artificial intelligence in healthcare","volume":"118","author":"Sadeghi","year":"2024","journal-title":"Comput Electr Eng"},{"key":"10.1016\/j.coi.2026.102818_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s41512-025-00213-8","article-title":"Explainable AI in healthcare: to explain, to predict, or to describe?","volume":"9","author":"Carriero","year":"2025","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.coi.2026.102818_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070904","article-title":"Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI","volume":"377","author":"Vasey","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2026.102818_sbref58","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41591-020-1037-7","article-title":"Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension","volume":"26","author":"Cruz Rivera","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102818_sbref59","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41591-020-1034-x","article-title":"AK: Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension","volume":"26","author":"Liu","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102818_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2016.18","article-title":"The FAIR Guiding Principles for scientific data management and stewardship","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Sci Data"},{"key":"10.1016\/j.coi.2026.102818_bib61","unstructured":"Regulation (EU) 2024\/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence and amending Regulations (EC) No 300\/2008, (EU) No 167\/2013, (EU) No 168\/2013, (EU) 2018\/858, (EU) 2018\/1139 and (EU) 2019\/2144 and Directives 2014\/90\/EU, (EU) 2016\/797 and (EU) 2020\/1828 (Artificial Intelligence Act) (Text with EEA relevance); 2024."},{"key":"10.1016\/j.coi.2026.102818_bib62","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41591-024-03425-5","article-title":"The TRIPOD-LLM reporting guideline for studies using large language models","volume":"31","author":"Gallifant","year":"2025","journal-title":"Nat Med"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:48:15Z","timestamp":1788425295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526000956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":62,"alternative-id":["S0952791526000956"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102818","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of artificial intelligence in clinical trials in adult and pediatric rheumatology","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102818"}}